You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

RIFAMPIN AND ISONIAZID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rifampin And Isoniazid patents expire, and when can generic versions of Rifampin And Isoniazid launch?

Rifampin And Isoniazid is a drug marketed by Hikma Intl Pharms and is included in one NDA.

The generic ingredient in RIFAMPIN AND ISONIAZID is isoniazid; rifampin. There are five drug master file entries for this compound. Additional details are available on the isoniazid; rifampin profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RIFAMPIN AND ISONIAZID?
  • What are the global sales for RIFAMPIN AND ISONIAZID?
  • What is Average Wholesale Price for RIFAMPIN AND ISONIAZID?
Summary for RIFAMPIN AND ISONIAZID
Drug patent expirations by year for RIFAMPIN AND ISONIAZID
Recent Clinical Trials for RIFAMPIN AND ISONIAZID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tuberculosis Trials ConsortiumPhase 2/Phase 3
First Affiliated Hospital of Zhejiang UniversityPhase 3
Instituto de Salud Carlos IIIPhase 4

See all RIFAMPIN AND ISONIAZID clinical trials

US Patents and Regulatory Information for RIFAMPIN AND ISONIAZID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms RIFAMPIN AND ISONIAZID isoniazid; rifampin CAPSULE;ORAL 065221-001 Jul 29, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.